A large-scale prevalence survey of blindness and visual impairment (The Andhra Pradesh Eye Diseases Study [APEDS1]) was conducted between 1996-2000 on 10,293 individuals of all ages in three rural and one urban clusters in Andhra Pradesh, Southern India. More than a decade later (June 2009-March 2010), APEDS1 participants in rural clusters were traced (termed APEDS2) to determine ocular risk factors for mortality in this longitudinal cohort.
Methods and Findings
Mortality hazard ratio (HR) analysis was performed for those aged >30 years at APEDS1, using Cox proportional hazard regression models to identify associations between ocular exposures and risk of mortality. Blindness and visual impairment (VI) were defined using Indian definitions. 799/4,188 (19.1%) participants had died and 308 (7.3%) had migrated. Mortality was higher in males than females (p<0.001). In multivariable analysis, after adjusting for age, gender, diabetes, hypertension, body mass index, smoking and education status the mortality HR was 1.9 (95% CI: 1.5-2.5) for blindness; 1.4 (95% CI: 1.2-1.7) for VI; 1.8 (95% CI: 1.4-2.3) for pure nuclear cataract, 1.5 (95% CI: 1.1-2.1) for pure cortical cataract; 1.96 (95% CI: 1.6-2.4) for mixed cataract, 2.0 (95% CI: 1.4-2.9) for history of cataract surgery, and 1.58 (95% CI: 1.3-1.9) for any cataract. When all these factors were included in the model, the HRs were attenuated, being 1.5 (95% CI: 1.1-2.0) for blindness and 1.2 (95% CI: 0.9-1.5) for VI. For lens type, the HRs were as follows: pure nuclear cataract, 1.6 (95% CI: 1.3-2.1); pure cortical cataract, 1.5 (95% CI: 1.1-2.1); mixed cataract, 1.8 (95% CI: 1.4-2.2), and history of previous cataract surgery, 1.8 (95% CI: 1.3-2.6).
Citation: Khanna RC, Murthy GVS, Giridhar P, Krishnaiah S, Pant HB, Palamaner Subash Shantha G, et al. (2013) Cataract, Visual Impairment and Long-Term Mortality in a Rural Cohort in India: The Andhra Pradesh Eye Disease Study. PLoS ONE8(10): e78002. https://doi.org/10.1371/journal.pone.0078002
Editor: Mingguang He, Zhongshan Ophthalmic Center, China
Received: May 23, 2013; Accepted: September 9, 2013; Published: October 25, 2013
Copyright: © 2013 Khanna et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by Sightsavers International. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
There has been inconsistency in the association between mortality and visual impairment (VI) [1-12] with some studies demonstrating a positive association [2-4,6-11], whereas others do not [1,5,12]. Similar findings have been reported for cataract [1-6,8,10-19], diabetic retinopathy (DR) [6,11,12,16] and age related macular degeneration (ARMD) [1-3,5,6,8,10-13,16]. These inconsistencies could be explained by differences in study design, age of the study participants, follow-up intervals, the definitions used and in the analytical approach to controlling for potential confounders.
Different biological mechanisms have been proposed for the association between mortality and certain eye diseases [20-24]. Possible explanations are that eye diseases such as cataract are markers of biological aging and that common ocular conditions may share a common attribute with conditions associated with increased mortality [20,22]. Another possible reason is that the excess mortality is a consequence of VI, which increases the risk of falls and depression, particularly in the elderly .
As there is a paucity of data on the risk of mortality among those who are blind and visually impaired from India, we explored this association through a follow-up study of participants in the Andhra Pradesh Eye Disease Study (APEDS) .
Material and Methods
This study was approved by the Institutional Review Board of L V Prasad Eye Institute and was conducted adhering to the Tenets of the Declaration of Helsinki. This study was part of a tracing exercise of a longitudinal cohort (that was studied more than a decade ago), in order to identify participants who were available for a reexamination. The causes of death were noted for participants who had died during this period. Since the majority of the participants were not literate enough to either read or sign the consent form, a verbal consent was obtained in the presence of the village head after explaining the purpose of this exercise to them. This process was documented in our study protocol and was further approved by the Ethics Committee of the L.V. Prasad Eye Institute. For brevity, the original APEDS survey will be called APEDS1 and the recent study described here will be APEDS2, which was limited to individuals aged 30 years or above at the time of APEDS1.
Methods used in APEDS1
The initial Andhra Pradesh Eye Disease Study (APEDS1) has been described elsewhere [25,26]. Briefly, the study was conducted in the South Indian state of Andhra Pradesh (AP) between 1996 and 2000 in one urban and three rural areas representative of the population of the State. The principle aim of APEDS was a) to estimate the prevalence of eye diseases, blindness and VI, b) to determine risk factors associated with the major eye diseases, c) to assess the effect of blindness and VI on quality of life (QoL) and d) to investigate barriers to the uptake of services. The study sample consisted individuals of all ages and was selected using stratified random sampling with probability proportionate to size procedures so that each social group (caste) was adequately represented in each area. The sample size (n = 10,293) was calculated to give a precise estimate of the prevalence of blindness of 0.5% for eye disease of least prevalence in those aged ≤30 years (ocular trauma) and >30 years (ARMD). Hence, a sample size of 5000 in each of these two age groups (≤ 30 years and >30 years) was chosen such that the estimation of these diseases in their respective age group would have similar precision. Participants were recruited from four areas, one urban area (Hyderabad, n=2,522) and three rural areas, namely Tanuku (West Godavari district, n=2,503), Mudhole (Adilabad district, n=2690), and Thoodukurthy (Mahabubnagar district, n=2578).
Interviews, standard eye examinations, and anthropometric measurements such as blood pressure, weight and height were undertaken at examination sites set up for the study. Participants aged more than 15 years were administered a structured questionnaire by trained interviewers to collect information on risk factors for eye diseases (e.g. severe diarrhoea), presence of systemic diseases (e.g. hypertension, diabetes, leprosy), behaviours (e.g. current or previous smoking, alcohol consumption, or chewing tobacco) and regular use of medication (steroids, multivitamins etc). Clinical examinations were performed by a team comprising four ophthalmologists and four optometrists who had undergone a detailed training.
Standard examination included distance and near visual acuity (VA), both presenting (PVA) and best corrected (BCVA) after refraction, measured for each eye separately using logMAR (logarithm of minimum angle of resolution) charts. All subsequently underwent a full ophthalmic examination including slit lamp biomicroscopy, dilated fundus examination and lens grading using the Lens Opacities Classification System (LOCS-III) and the Wilmer classification [27,28]. Participants who were unable to visit the clinic due to physical ailment or other reasons were examined at home using similar methods. However, gonioscopy, examination with 78 diopter lens, automated visual fields, and photography could not be accomplished in these participants.
Blindness was defined using Indian definitions as PVA less than 6/60 or central visual field less than 20° in the better eye . VI was defined as PVA less than 6/18-6/60 or equivalent visual field loss . The lens was examined after fully dilating the pupils. Nuclear opacity was graded clinically using the Lens Opacity and Classification System III (LOCS III)  and cortical and posterior subcapsular cataract were graded using the Wilmer classification . Because different types of cataract frequently co-exist, for analysis we considered pure nuclear, pure cortical, pure posterior subcapsular cataract (PSC) and mixed type of cataract. Those with total cataract were grouped under mixed cataract category and those having undergone cataract surgery (unilateral / bilateral) were treated as separate group. We defined the presence of pure nuclear cataract (NC) as at least one eye showing nuclear opalescence of grade 3.0 or higher on LOCSIII . Pure cortical cataract (CC) was considered present if at least one eye had a Wilmer grade of 2 or higher. Pure PSC was considered present if at least one eye had a Wilmer grade of 1 or higher . Pure nuclear, cortical or PSC subgroup had isolated cataract without the presence of other subtypes. Mixed cataract was defined as at least one eye showing combination of any two type of opacity and any cataract was defined as having any of the above mentioned opacity, including history of cataract surgery . For analysis, the opacity in the most affected eye was used. ARMD was defined as based on International Classification and Grading System  and DR was defined based on the modification of the standard classification system .
Hypertension was defined as present if the participant gave a history of high blood pressure diagnosed by a physician and / or current treatment with antihypertensive medications and / or a had a blood pressure reading of ≥140/90 mm Hg. Diabetes was defined as present if a participant gave a history of diabetes and / or was taking diabetic medication and / or diabetic retinopathy was detected on clinical examination. The duration of diabetes since diagnosis was also documented. Body mass index (BMI) was calculated from the measured height and weight according to the formula weight (in kilograms) divided height (in meters) squared. World Health Organization categories were used i.e. underweight (BMI <18.5), normal (18.5 ≤ BMI < 25), over weight (25 ≤ BMI < 30), and obese (BMI ≥ 30) [34,35]. For smoking, participants were categorized as never smoker, former smoker and current smoker. Current and former smokers were those who had smoked for a minimum of 1 year. Participants who had never smoked, or had smoked for less than 1 year were considered “never smokers”. Details of smoking used in analysis have been published elsewhere .
The cause of visual loss (VI or blindness) in each eye was determined and documented by an ophthalmologist in consultation with the principal investigator. For instance, if cataract and a posterior-segment lesion of the optic nerve or retina coexisted and removal of cataract was unlikely to restore vision, the cause of blindness was attributed to the posterior-segment lesion. On the other hand, if dense cataract was present that prevented a clear view of the posterior segment and with no other signs suggestive of any other cause of visual loss, the cause of blindness was considered to be cataract. If index myopia was present due to cataract, and even if the vision improved with refraction, the cause of blindness was attributed to cataract as it was the major underlying cause. If the causes differed between eyes, the cause most amenable to treatment was selected as the cause of blindness for the person.
Methods used in APEDS2
Extensive changes have taken place in urban and semi-urban Hyderabad over the last decade, and the original urban area could not be delineated. Hence, the tracing exercise, undertaken from 2009-2010 was limited to the rural clusters. The purpose of tracing the original participants was as follows:
- To assess the mortality rate amongst those who were aged 30 years and above at APEDS1 and
- To determine factors at APEDS1 that predicted subsequent mortality e.g. lens status, VI, ARMD, after adjusting for confounders
At APEDS1, 70 out of 94 clusters were included in the rural sample and 7,771 / 8,832 (88%) of those enumerated were clinically examined between 1996 and 2000. Of these, 4,188 (53.9%) were adults aged 30 years and above.
Names and addresses of APEDS1 participants were extracted from the existing database. The field investigators visited each cluster to gather further information on the APEDS I participants. Prior to field work, a pilot study was undertaken during which the instruments were standardized. Following this training phase, all surviving participants were interviewed in detail by trained field investigators using standard methods. In households where the original participant(s) had either died or migrated, a structured questionnaire was administered by trained interviewers to the present head of household to collect information on the cause and/or the reason of death and the year of death and migration, as applicable. In situations where the entire household had migrated, questions were administered to neighbors. As formal death certificates were not available, the cause of death was based on verbal autopsy using WHO recommended methods.
Data analysis was performed using STATA 11 . For comparison of two continuous variables, student’s t test was used, while for multiple groups, one-way analysis of variance (ANOVA) was used. For categorical data, Fisher’s exact test was used and for analysis of risk factors for mortality and VI, cataract and ARMD, Cox-proportional hazard model was used . Test of significance for survival curve was assessed using the log-rank test. Multi-colinearity between variables was assessed using variance inflation factors, and proportionality of the model was tested based on Schoenfeld residuals. Interaction effects were tested between gender and ocular parameters (VI, cataract and ARMD), diabetes and different morphologies of cataract (pure cortical, pure nuclear and mixed) and VI and cataract (pure nuclear cataract, pure cortical cataract, mixed cataract and history of cataract surgery).
The interval between APEDS1 and APEDS2 ranged from 10-12 years (mean 11 years; SD: 0.81 year). Data were available on all the 4,188 individuals aged 30 years and above examined in rural clusters during APEDS1: 799 (19.1%) had died by APEDS2; 308 (7.3%) had migrated and 3,081 (73.6%) were still living in the area (i.e. they were “available”) (Figure 1). There were 1,964/4188 (46.9%) males in this dataset.
Migration was higher (53.9%) in females than males, and was higher in one of the rural areas (Mahabubnagar, 11.3%). There was no significant difference in the mean age of those available in APEDS2 (mean 45 years; SD: 11.22 years) compared to those who had migrated (mean 44.39 years; SD: 12.48 years; P=0.43), but those who had died were significantly older (mean 60.23 years; SD: 12.1 years; P<0.001).
Mortality rates were higher in males among those who were illiterate, smokers, had hypertension and diabetes (Table 1). There was no association between mortality and alcohol consumption (P=0.19).
|N (%)||N (%)||N (%)|
|Age group (years)|
|30 - 39||1338 (39.5)||60 (7.5)||1398 (33.4)|
|40 - 49||939 (27.7)||90 (11.3)||1029 (24.6)|
|50 -59||632 (18.7)||155 (19.4)||787 (18.8)|
|60 - 69||397 (11.7)||319 (39.9)||716 (17.1)|
|≥ 70||83 (2.5)||175 (21.9)||258 (6.2)|
|Male||1533 (45.2)||431 (53.9)||1964 (46.9)|
|Female||1856 (54.8)||368 (46.1)||2224 (53.1)|
|Illiterate||2130 (62.9)||551 (69)||2681 (64)|
|Class 1-5*||707 (20.9)||173 (21.7)||880 (21.2)|
|Class 6-10||439 (13)||57 (7.1)||496 (11.8)|
|Class 11 and above*||113 (3.3)||18 (2.3)||131 (3.1)|
|Absent||2230 (65.8)||410 (51.3)||2640 (63)|
|Present||1159 (34.2)||389 (48.7)||1548 (37)|
|Absent||3345 (98.8)||763 (95.5)||4108 (98.1)|
|Present||42 (1.2)||36 (4.5)||78 (1.9)|
|Never smoker||2817 (83.2)||603 (75.5)||3420 (81.7)|
|Former smoker||280 (8.3)||48 (6)||328 (7.8)|
|Current smoker||291 (8.6)||148 (18.5)||439 (10.5)|
|Body Mass Index (BMI)|
|Normal||1636 (49.7)||295 (40.7)||1931 (48.1)|
|Under weight||1369 (41.6)||360 (49.7)||1729 (43.1)|
|Over weight*||236 (7.2)||55 (7.6)||291 (7.3)|
|Obese*||49 (1.5)||15 (2.1)||214 (1.6)|
|Never Drinker||2254 (66.5)||515 (64.5)||2769 (66.1)|
|Former Drinker||836 (24.7)||221 (27.7)||1057 (25.2)|
|Current Drinker||298 (8.8)||63 (7.9)||361 (8.6)|
Univariate analysis for eye diseases detected during APEDS1 showed that subsequent mortality was higher for those with ARMD and in those with blindness or VI. Individuals either with pure nuclear cortical, posterior subcapsular and mixed cataract, or a history of cataract surgery (irrespective of post-operative visual acuity) or any cataract also had a higher risk of mortality compared to those with minimal or no lens opacities at APEDS1 (Table 2)
|N (%)||N (%)||N (%)|
|Visual acuity (VA)|
|6/6-6/18||2665 (78.7)||326 (40.9)||2991 (71.5)|
|<6/18-6/60||620 (18.3)||367 (46)||987 (23.6)|
|<6/60||101 (3)||105 (13.2)||206 (4.9)|
|Pure Nuclear Cataract|
|Yes||194 (5.7)||160 (20)||354 (8.5)|
|No||3195 (94.3)||639 (80)||3834 (91.5)|
|Pure Cortical Cataract|
|Yes||106 (3.1)||43 (5.4)||149 (3.6)|
|No||3283 (96.9)||756 (94.6)||4039 (96.4)|
|Pure Posterior subcapsular cataract|
|Yes||74 (2.2)||27 (3.4)||101 (2.4)|
|No||3315 (97.8)||772 (96.6)||4087 (97.6)|
|Yes||205 (6.1)||201 (25.2)||406 (9.7)|
|No||3184 (94)||598 (74.8)||3782 (90.3)|
|History of cataract surgery|
|Yes||48 (1.4)||49 (6.1)||97 (2.3)|
|No||3335 (98.6)||749 (93.9)||4084 (97.7)|
|Yes||627 (18.5)||480 (60.2)||1104 (26.4)|
|No||2756 (81.5)||318 (39.8)||3077 (73.6)|
|Present||32 (0.9)||22 (2.7)||54 (1.3)|
|Absent||3356 (99.1)||777 (97.3)||4133 (98.7)|
To further evaluate associations between ocular and systemic diseases, demographic and lifestyle factors with mortality, data were analysed using the Cox proportion hazard model.
|Risk Factors||Univariable analysis|
|Risk Factors Categories||Hazard ratio||95% CI|
|Age group (yrs)|
|30 - 39||1.00|
|40 - 49||2.08||1.49, 2.88|
|50 - 59||4.94||3.66, 6.66|
|60 - 69||13||9.84, 17.15|
|≥ 70||24.82||18.46, 33.38|
|Class 1 - 5||0.97||0.82, 1.16|
|Class 6 - 10||0.56||0.43, 0.74|
|Class 11 and above||0.74||0.47, 1.19|
|Body Mass Index|
|Former smoker||1.80||1.37, 2.38|
|Heavy smoker||1.42||1.18, 1.71|
|Risk Factors||Risk Factors categories||Hazard ratio||95% CI|
|<6/18 - 6/60||3.88||3.34, 4.51|
|Pure nuclear cataract|
|Pure cortical cataract|
|Pure PSC* cataract|
|History of cataract surgery|
|Any type of cataract, including cataract surgery|
In the multivariable analysis, four models were considered. Model 1 included all the VI categories; model 2 included lens morphology and those who had undergone cataract surgery; model 3 included any cataract with all the VI categories and ARMD and model 4 included all the ocular factors (grades of VI, lens morphology, those who had undergone cataract surgery and ARMD). All these models were adjusted for systemic diseases, demographic and lifestyle factors (age, gender, education level, diabetes, hypertension, BMI and smoking status; Table 5). The findings were similar in Models 1, 2 and 3 in the univariate analysis, but the hazard ratios (HRs) were attenuated after adjusting for confounders. In Model 2, PSC was no longer associated with an increased risk for mortality (HR=1.00, 95% Confidence Interval (CI): 0.62, 1.58) and in Model 4, VI was no longer associated with mortality (HR=1.19, 95% CI: 0.97, 1.45). After adjusting for systemic diseases, demographic and lifestyle factors (age, gender, education level, diabetes, hypertension, BMI and smoking status), ARMD (HR=1.44, 95% CI: 0.92, 2.26) was no longer associated with mortality (data not shown). These associations were consistent even when age was used as a continuous variable or using the forward and backward stepwise method (data not shown).
|Risk Factors||Risk Factors categories||Model 1$All VI categories||Model 2$Lens morphology||Model 3$VI, any cataract and ARMD||Model 4$VI, lens morphology and ARMD|
|HR (95% CI)||HR (95% CI)||HR (95% CI)||HR (95% CI)|
|≥6/18||1.00 (Ref)||----||1.00 (Ref)||1.00 (Ref)|
|<6/18-6/60||1.42 (1.18, 1.69)*||----||1.23 (1.01-1.48)*||1.19 (0.9, 1.45)|
|<6/60||1.89 (1.45, 2.47)*||----||1.57 (1.19-2.07)*||1.46 (1.1, 1.95)*|
|Schoenfeld test #||0.15||----||----||----|
|No||----||----||1.00 (Ref)||1.00 (Ref)|
|Yes||----||----||1.26 (0.8-1.98)||1.25 (0.79, 1.97)|
|Pure nuclear cataract|
|No||----||1.00 (Ref)||----||1.00 (Ref)|
|Yes||----||1.8 (1.43, 2.27)*||----||1.61 (1.25, 2.07)*|
|Pure cortical cataract|
|No||----||1.00 (Ref)||----||1.00 (Ref)|
|Yes||----||1.48 (1.05, 2.08)*||----||1.49 (1.06, 2.09)*|
|Pure PSC* cataract|
|No||----||1.00 (Ref)||----||1.00 (Ref)|
|Yes||----||1.00 (0.62, 1.58)||----||0.97 (0.61, 1.54)|
|No||----||1.00 (Ref)||----||1.00 (Ref)|
|Yes||----||1.96 (1.57, 2.44)*||----||1.75 (1.38, 2.23)*|
|Previous cataract surgery|
|No||----||1.00 (Ref)||----||1.00 (Ref)|
|Yes||----||2.01 (1.41, 2.88)*||----||1.82 (1.26, 2.62)*|
|Any type of cataract, including cataract surgery|
No interactions were observed between gender, ocular parameters (VI, cataract and ARMD) and mortality risk or between diabetes and different morphology of cataract (pure cortical, pure nuclear and mixed). Similar results were observed with VI and different lens morphology (pure nuclear cataract, pure cortical cataract, mixed cataract) and history of cataract surgery.
Many relatives reported symptoms rather than diagnoses and so the actual cause of death could not be determined with any degree of accuracy in high proportion of cases.
Life table graphs showing the probability of death by follow up time (unadjusted and adjusted for age and gender) and presence of VI and morphology of cataract at baseline are shown in figures 2 and 3. Participants with VI or blindness (uncontrolled and after controlling for age and gender) were at increase risk of mortality (P<0.001;Figure 2). Similarly, those with pure nuclear, cortical and PSC were also at increase risk of mortality than those without any cataract (P<0.001).
In this population based study in Andhra Pradesh, India, the 10-12 year cumulative mortality in those aged 30 years and above at baseline was 19.1% (1.7%/year). This was lower than other longitudinal population based studies, such as the Beaver Dam Study (BDS) (32%; age group 43-84 years and 14 years follow-up) , Blue Mountain Eye Study (BMES) (28.9%; age group 49 years or older; 11 years follow-up)  and The Copenhagen City Eye Study (CCES) (60.9%; age group 60-80 years; 14 years follow-up)  (Table 6). In these studies, all participants were older at baseline, and follow up intervals varied. Analysis of APEDS2 data using comparable ages at APEDS1 to those in the other studies showed that average annual mortality rates were similar, being slightly higher in our study, For example, in BMES, which also had 11 years of follow up, mortality among those aged 43-84 years in was 28.9% compared to 36.3% in APEDS2. As the data was not age-standardized, the differences may reflect the varied demographics differences between samples as well as differences in life expectancy.
|Sr. No||Population-based studies (year of publication)||Follow-up duration ( No. of years)||Age group (Years)||No. of participants at baseline||Incidence of mortality: N (%)|
|1||Framingham Heart Study (1985)[ 16]||4.8-8||52-85||1945||312 (16)|
|2||The Beaver Dam Eye Study (1995)[ 5]||5||43-84||4926||467 (9.5)|
|3||Salisbury Eye Evaluation (1997)[ 18]||2||65-84||2520||147 (5.8)|
|4||Barbados Eye Study (2001)[ 14]||4||40-84||4709||306 (6.8)|
|5||Melbourne Visual Impairment Project (2001)[ 8]||5||40-98||3271||231 (7.1)|
|6||Blue Mountain Eye Study (2001)[ 11]||5||>=49||3654||604 (16.5)|
|7||North London Eye Study (2002)[ 17]||4||>65||1502||222 (14.7)|
|8||The Rotterdam Study (2003)[ 13]||7||>=55||6339||1359 (21.4)|
|9||Priverno Eye Study (2004)[ 15]||7||45-69||860||44 (5.1)|
|10||Age Related Eye Disease Study (2004)[ 2]||9||55-81||4753||534 (11)|
|11||The Copenhagen City Eye Study (2005)[ 1]||14||60-80||964||577 (60.9)|
|12||The Beaver Dam Eye Study (2006)[ 6]||14||43-84||4926||1576 (32)|
|13||Blue Mountain Eye Study (2007)[ 3]||11||>=49||3654||1039 (28.9)|
|14||Tanjong Pagar Study (2008)[ 4]||7||>=40||1232||126 (10.2)|
|15||Beijing Eye Study (2008)[ 12]||5||>=40||4439||143 (3.2)|
|16||Harbin Eye Study (2011)[ 7]||4||50-96||5057||214 (4.2)|
|17||APEDS2 (Present study)||11||>=30||4188||799 (19.1)|
In our study we also found that VI and blindness were associated with all causes of mortality (Model 1). The association, though attenuated, held true even after including other age related eye diseases in the model (model 4). This association has been reported in previous studies (Table 7) [2-4,6-11]. The possible explanations could be that 1) visual acuity is associated with markers of frailty and frailty predicts mortality, 2) there may be common underlying genetic mechanisms in eye diseases and mortality , 3) environmental exposures may also increase the risk of eye disease and mortality, and finally, 4) there is some evidence that low visual acuity itself increases the risk of mortality through falls, accidents and depression [21,23,24]. A further explanation is that the findings may be due to residual confounding, as we were only able to adjust for a limited number of variables.
|Sr. No||Population-based studies||VI / blindness||Nuclear||Cortical||PSC||Mixed||Any cataract||Cataract surgery||ARMD|
|1||Framingham Heart Study (1985)||NA||+ in diabetics||+ in diabetics||+ in diabetics||NA||NA||NA||NA|
|2||The Beaver Dam Eye Study (1995)||-||+||-||-||NA||-||-||-|
|3||Salisbury Eye Evaluation (1997)||NA||+||-||-||+||NA||-||NA|
|4||Barbados Eye Study (2001)||NA||+||-||-||+||NA||NA||NA|
|5||Melbourne Visual Impairment Project (2001)||+||-||+||-||NA||NA||-||-|
|6||Blue Mountain Study (2001)||+||+||+||+||NA||NA||-||-|
|7||North London Eye Study (2002)||NA||+ in non-diabetics women||+ in non-diabetics women||+ in non-diabetics women||NA||NA||NA||NA|
|8||The Rotterdam Study (2003)||NA||-||-||-||-||-||-||-|
|9||Priverno Eye Study (2004)||NA||+||-||-||-||NA||+||NA|
|10||Age Related Eye Disease Study (2004)||+||+||-||-||NA||+||+||+ in advance ARMD|
|11||The Copenhagen City Eye Study (2005)||-||NA||NA||NA||NA||-||NA||+ for women|
|12||The Beaver Dam Eye Study (2006)||+||+||+||-||NA||+||-||-|
|13||Blue Mountain Study (2007)||+ for <75 years||+||+||+||NA||+||-||+ for <75 years|
|14||Tanjong Pagar Study (2008)||+||-||-||-||NA||NA||-||NA|
|15||Beijing Eye Study (2008)||-||-||-||-||NA||NA||NA||NA|
|16||Harbin Eye Study (2011)||+||NA||NA||NA||NA||NA||NA||NA|
|17||APEDS2 (Present study)||+||+||+||-||+||+||+||-|
Similar to most studies (Table 7; including long term studies such as BDS, BMES), we found an association between mortality and nuclear cataract [2,3,5,6,11,14-18,39], cortical cataract [3,6,11,16,17] and mixed cataract [2,3,6,14,18,19] and any type of cataract with mortality [2,6,11]. The sample size was probably too small for PSC to give statistically significant findings in our study. The association between cataract and mortality has been reported across studies undertaken in different geographic locations and ethnic groups, at different times using different cataract classification systems, which suggests that biological processes are responsible for both. Changes inside the lens may reflect molecular , cellular and epigenetic mechanisms, including glycosulation and denaturation of proteins and oxidative stress that also impact on systemic health . These mechanisms may be mediated in part by behavioural and/or environmental exposures such as cigarette smoking and ultraviolet light, which are risk factors for nuclear and cortical cataract respectively [41,42]. In India, severe dehydration has also been shown to be associated with early onset of cataract .
Our finding of increased mortality in individuals who underwent cataract surgery is not consistently reported in other studies (Table 7). Some studies have exhibited positive associations [2,15,44-50] while other were negative [3-6,8,11,13,18,19]. These differences could be explained by differences in study design, age at surgery, the degree of lens opacities at surgery as well as differences in follow-up rates. Some studies were hospital based rather than population based, which may bias the findings. In our study, the association of mortality with cataract surgery (Model 4) remained consistent even after adjusting for visual acuity.
ARMD was not associated with mortality in our study after adjusting for confounders, which probably reflects the low prevalence of the disease in the population and the small number of cases (Table 7).
The large population based sample and high response rates are major strengths of our study. A limitation is that change in exposure status over time was not assessed, but this would also have reduced the magnitude of the effect. Data on the causes of mortality also depended on verbal autopsy and many relatives reported symptoms rather than diseases, which limited the data on causes of mortality. However, despite these limitations, our observations are of importance as this is the first time that such data have been reported from a rural setting in Asia where life expectancy, access to health care services and risk factors are very different from the developed nations. Our findings support the hypothesis that cataract reflect systemic ageing and that lens may be a useful biomarker of ageing .
We would also like to thank the following members of the team involved with the study: Mr. Ramakrishna who led the entire team of Mr. Srinivas N, Mr. Satyanarayana N V V and Mr. Gopalakrishna A from Tanuku region; Mr. Sainath M, Mr. Nagesh K and Mr. Lankesh K from Mudhole region and Mr. Lingamaiah S, Mr. Channaiah M and Mr. Yella Goud R from Thoodukurthy region
Conceived and designed the experiments: RCK GVSM CG GNR. Performed the experiments: RCK PG. Analyzed the data: RCK SK HBP GPSS. Contributed reagents/materials/analysis tools: RCK SK HBP GPSS SC. Wrote the manuscript: RCK GVSM PG SK HBP GPSS SC CG GNR.
- 1. Buch H, Vinding T, la Cour M, Jensen GB, Prause JU et al. (2005) Age-related maculopathy: a risk indicator for poorer survival in women: the Copenhagen City Eye Study. Ophthalmology 112: 305-312. doi:10.1016/j.ophtha.2004.08.025. PubMed: 15691568.
- 2. Clemons TE, Kurinij N, Sperduto RD (2004) Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 122: 716-726.
- 3. Cugati S, Cumming RG, Smith W, Burlutsky G, Mitchell P et al. (2007) Visual impairment, age-related macular degeneration, cataract, and long-term mortality: the Blue Mountains Eye Study. Arch Ophthalmol 125: 917-924. doi:10.1001/archopht.125.7.917. PubMed: 17620571.
- 4. Foong AW, Fong CW, Wong TY, Saw SM, Heng D et al. (2008) Visual acuity and mortality in a chinese population. The Tanjong Pagar Study. Ophthalmology 115: 802-807. doi:10.1016/j.ophtha.2007.04.066. PubMed: 17765312.
- 5. Klein R, Klein BE, Moss SE (1995) Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 113: 333-339. doi:10.1001/archopht.1995.01100030089026. PubMed: 7887847.
- 6. Knudtson MD, Klein BE, Klein R (2006) Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study. Arch Ophthalmol 124: 243-249. doi:10.1001/archopht.124.2.243. PubMed: 16476894.
- 7. Li Z, Sun D, Liu P, Zhang L, Bai J et al. (2011) Visual impairment and mortality in a rural adult population (the Southern Harbin eye study). Ophthal Epidemiol 18: 54-60.
- 8. McCarty CA, Nanjan MB, Taylor HR (2001) Vision impairment predicts 5 year mortality. Br J Ophthalmol 85: 322-326. doi:10.1136/bjo.85.3.322. PubMed: 11222339.
- 9. Taylor HR, Katala S, Muñoz B, Turner V (1991) Increase in mortality associated with blindness in rural Africa. Bull World Health Organ 69: 335-338. PubMed: 1893509.
- 10. Thiagarajan M, Evans JR, Smeeth L, Wormald RP, Fletcher AE (2005) Cause-specific visual impairment and mortality: results from a population-based study of older people in the United Kingdom. Arch Ophthalmol 123: 1397-1403. doi:10.1001/archopht.123.10.1397. PubMed: 16219731.
- 11. Wang JJ, Mitchell P, Simpson JM, Cumming RG, Smith W (2001) Visual impairment, age-related cataract, and mortality. Arch Ophthalmol 119: 1186-1190. doi:10.1001/archopht.119.8.1186. PubMed: 11483087.
- 12. Xu L, Wang YX, Wang J, Jonas JJ (2009) Mortality and ocular diseases: the Beijing Eye Study. Ophthalmology 116: 732-738. doi:10.1016/j.ophtha.2008.11.003. PubMed: 19195709.
- 13. Borger PH, van Leeuwen R, Hulsman CA, Wolfs RC, van der Kuip DA et al. (2003) Is there a direct association between age-related eye diseases and mortality? The Rotterdam Study. Ophthalmology 110: 1292-1296. doi:10.1016/S0161-6420(03)00450-0. PubMed: 12867381.
- 14. Hennis A, Wu SY, Li X, Nemesure B, Leske MC (2001) Lens opacities and mortality : the Barbados Eye Studies. Ophthalmology 108: 498-504. doi:10.1016/S0161-6420(00)00542-X. PubMed: 11237904.
- 15. Nucci C, Cedrone C, Culasso F, Cesareo M, Regine F et al. (2004) Association between lens opacities and mortality in the Priverno Eye Study. Graefes Arch Clin Exp Ophthalmol 242: 289-294. doi:10.1007/s00417-003-0837-z. PubMed: 14740225.
- 16. Podgor MJ, Cassel GH, Kannel WB (1985) Lens changes and survival in a population-based study. N Engl J Med 313: 1438-1444. doi:10.1056/NEJM198512053132303. PubMed: 4058547.
- 17. Reidy A, Minassian DC, Desai P, Vafidis G, Joseph J et al. (2002) Increased mortality in women with cataract: a population based follow up of the North London Eye Study. Br J Ophthalmol 86: 424-428. doi:10.1136/bjo.86.4.424. PubMed: 11914212.
- 18. West SK, Muñoz B, Istre J, Rubin GS, Friedman SM et al. (2000) Mixed lens opacities and subsequent mortality. Arch Ophthalmol 118: 393-397. doi:10.1001/archopht.118.3.393. PubMed: 10721963.
- 19. Williams SL, Ferrigno L, Mora P, Rosmini F, Maraini G (2002) Baseline cataract type and 10-year mortality in the Italian-American Case-Control Study of age-related cataract. Am J Epidemiol 156: 127-131. doi:10.1093/aje/kwf012. PubMed: 12117703.
- 20. Klein BE, Klein R, Knudtson MD, Lee KE (2005) Frailty, morbidity and survival. Arch Gerontol Geriatr 41: 141-149. doi:10.1016/j.archger.2005.01.002. PubMed: 16085065.
- 21. Klein BE, Klein R, Lee KE, Cruickshanks KJ (1998) Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study. Ophthalmology 105: 160-164. doi:10.1016/S0161-6420(98)91911-X. PubMed: 9442793.
- 22. Pathai S, Shiels PG, Lawn SD, Cook C, Gilbert C (2012) The eye as a model of ageing in translational research - Molecular, epigenetic and clinical aspects. Ageing Res Rev 12: 490-508. PubMed: 23274270.
- 23. Rumsfeld JS, Jones PG, Whooley MA, Sullivan MD, Pitt B et al. (2005) Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J 150: 961-967. doi:10.1016/j.ahj.2005.02.036. PubMed: 16290972.
- 24. Wang JJ, Mitchell P, Smith W, Cumming RG, Attebo K (1999) Impact of visual impairment on use of community support services by elderly persons: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 40: 12-19. PubMed: 9888421.
- 25. Dandona R, Dandona L, Naduvilath TJ, Nanda A, McCarty CA (1997) Design of a population-based study of visual impairment in India: The Andhra Pradesh Eye Disease Study. Indian J Ophthalmol 45: 251-257. PubMed: 9567024.
- 26. Dandona L, Dandona R, Srinivas M, Giridhar P, Vilas K et al. (2001) Blindness in the Indian state of Andhra Pradesh. Invest Ophthalmol Vis Sci 42: 908-916. PubMed: 11274066.
- 27. Chylack LT Jr., Wolfe JK, Singer DM, Leske MC, Bullimore MA et al. (1993) The Lens Opacities Classification System III. The Longitudinal Study of Cataract. Study. Group. Arch Ophthalmol 111: 831-836.
- 28. Taylor HR, West SK (1988) A simple system for the clinical grading of lens opacities. Yan Ke Xue Bao 4: 14-18. PubMed: 3240794.
- 29. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Nanda A et al. (1998) Is current eye-care-policy focus almost exclusively on cataract adequate to deal with blindness in India? Lancet 351: 1312-1316. doi:10.1016/S0140-6736(97)09509-3. PubMed: 9643793.
- 30. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Srinivas M et al. (1999) Burden of moderate visual impairment in an urban population in southern India. Ophthalmology 106: 497-504. doi:10.1016/S0161-6420(99)90107-0. PubMed: 10080205.
- 31. Krishnaiah S, Vilas K, Shamanna BR, Rao GN, Thomas R et al. (2005) Smoking and its association with cataract: results of the Andhra Pradesh eye disease study from India. Invest Ophthalmol Vis Sci 46: 58-65. doi:10.1167/iovs.04-0089. PubMed: 15623755.
- 32. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G et al. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39: 367-374. doi:10.1016/S0039-6257(05)80092-X. PubMed: 7604360.
- 33. Krishnaiah S, Das T, Nirmalan PK, Shamanna BR, Nutheti R et al. (2007) Risk factors for diabetic retinopathy: Findings from The Andhra Pradesh Eye Disease Study. Clin. Ophthalmologe 1: 475-482.
- 34. WHO (2006) Global Database on Body Mass Index.
- 35. Consultation WHO (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163.
- 36. WHO. Retrieved onpublished at whilst December year 1111 from http://www.who.int/healthinfo/statistics/mort_verbalautopsy.pdf. Accessed 8th August, 2013.
- 37. StataCorp (2009) Stata Statistical Software: Release 11 College Station, TX: StataCorp LP.
- 38. Cox DR (1972) Regressional models and life tables. J Roy Statist Soc Bull 34: 187-220.
- 39. Thompson JR, Sparrow JM, Gibson JM, Rosenthal AR (1993) Cataract and survival in an elderly nondiabetic population. Arch Ophthalmol 111: 675-679. doi:10.1001/archopht.1993.01090050109039. PubMed: 8489452.
- 40. Hammond CJ, Snieder H, Spector TD, Gilbert CE (2000) Genetic and environmental factors in age-related nuclear cataracts in monozygotic and dizygotic twins. N Engl J Med 342: 1786-1790. doi:10.1056/NEJM200006153422404. PubMed: 10853001.
- 41. Cruickshanks KJ, Klein BE, Klein R (1992) Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study. Am J Public Health 82: 1658-1662. doi:10.2105/AJPH.82.12.1658. PubMed: 1456342.
- 42. Taylor HR, West SK, Rosenthal FS, Muñoz B, Newland HS et al. (1988) Effect of ultraviolet radiation on cataract formation. N Engl J Med 319: 1429-1433. doi:10.1056/NEJM198812013192201. PubMed: 3185661.
- 43. Minassian DC, Mehra V, Jones BR (1984) Dehydrational crises from severe diarrhoea or heatstroke and risk of cataract. Lancet 1: 751-753. PubMed: 6143081.
- 44. Benson WH, Farber ME, Caplan RJ (1988) Increased mortality rates after cataract surgery. A statistical analysis. Ophthalmology 95: 1288-1292. PubMed: 3211506.
- 45. Hirsch RP, Schwartz B (1983) Increased mortality among elderly patients undergoing cataract extraction. Arch Ophthalmol 101: 1034-1037. doi:10.1001/archopht.1983.01040020036004. PubMed: 6870624.
- 46. Hu FB, Hankinson SE, Stampfer MJ, Manson JE, Colditz GA et al. (2001) Prospective study of cataract extraction and risk of coronary heart disease in women. Am J Epidemiol 153: 875-881. doi:10.1093/aje/153.9.875. PubMed: 11323318.
- 47. Knudsen EB, Baggesen K, Naeser K (1999) Mortality and causes of mortality among cataract-extracted patients. A 10-year follow-up. Acta Ophthalmol Scand 77: 99-102. doi:10.1034/j.1600-0420.1999.770122.x. PubMed: 10071159.
- 48. Meddings DR, Marion SA, Barer ML, Evans RG, Green B et al. (1999) Mortality rates after cataract extraction. Epidemiology 10: 288-293. doi:10.1097/00001648-199905000-00017. PubMed: 10230840.
- 49. Ninn-Pedersen K, Stenevi U (1995) Cataract patients in a defined Swedish population 1986-90: VII Inpatient and outpatient standardised mortality ratios. Br J Ophthalmol 79: 1115-1119. doi:10.1136/bjo.79.12.1115. PubMed: 8562547.
- 50. Street DA, Javitt JC (1992) National five-year mortality after inpatient cataract extraction. Am J Ophthalmol 113: 263-268. PubMed: 1543218.